Quantcast
Last updated on April 16, 2014 at 0:16 EDT

Latest multiple sclerosis Stories

2013-03-10 23:01:33

The http://www.SclerosisTreatment.com website, a division of Ironclad Integrity Ltd., reveals a new therapy based on plants, vitamins and correct nutrition to reduce fatigue, pain and other MS symptoms instead of drug intake. Denver, Colorado (PRWEB) March 10, 2013 According to http://www.Sclerosistreatment.com for the 2.5 million MS patients worldwide, the lack of a permanent cure for their condition is frustrating and puzzling. Conventional therapies to treat Multiple Sclerosis are based...

2013-03-10 16:20:35

SAN DIEGO, March 10, 2013 /PRNewswire-USNewswire/ -- The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). A study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013, suggests that early detection of PML may help improve survival and disability levels. The study...

2013-03-10 16:20:30

SAN DIEGO, March 10, 2013 /PRNewswire-USNewswire/ -- A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The study involved 23 people with MS who were taking beta-interferon treatment and had at least one relapse...

2013-03-07 08:28:14

Tightly Managed Specialty Pharmacy Benefits Can Cut Specialty Drug Trend in Half WASHINGTON, March 7, 2013 /PRNewswire/ -- A study presented today at the National Business Group on Health's (NBGH) Business Health Agenda 2013 conference in Washington, D.C., showed that, on average, employers that use multiple cost management programs had a 50 percent lower specialty drug trend than employers that did not use any specialty management programs. (Logo:...

2013-03-06 08:28:07

EXTON, Penn., March 6, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that 34 percent of surveyed U.S. neurologists have prescribed Genzyme's Aubagio to at least one of their multiple sclerosis (MS) patients at three months post-launch, a significant increase in trial rate from one month post-launch (16 percent). Data from the recently published LaunchTrends(®): Aubagio Wave 2 report...

2013-03-06 08:26:15

"MS in America" Top Line Results Available on Newly Launched MutipleSclerosis.Net PHILADELPHIA, March 6, 2013 /PRNewswire/ -- Health Union, LLC announced today that it has published the results from the "MS in America 2013" survey on its newly launched website http://MultipleSclerosis.Net. The survey covered a broad array of topics impacting people with Multiple Sclerosis, and was taken by 3,437 respondents making it one of the largest of its kind conducted with MS patients in the...

2013-03-04 08:24:56

Industry and Patient Groups Join Forces to Form an Alliance to Accelerate Drug Development CAMBRIDGE, Mass., March 4, 2013 /PRNewswire/ -- GNS Healthcare today announced that it has joined in the formation of Orion Bionetworks. This unique alliance will work to transform our understanding of and accelerate the drug development process for a wide variety of diseases, beginning with multiple sclerosis (MS). Using patient data from alliance members Accelerated Cure Project for Multiple...

2013-02-26 12:27:04

Leading Research Center for Multiple Sclerosis Takes Name of Benefactors NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- The Board of Directors of the Multiple Sclerosis Research Center of New York (MSRCNY) today announced the re-naming of the institution as the Tisch MS Research Center of New York. Representing a new model of healthcare, the research center, coupled with its clinical affiliate, the International Multiple Sclerosis Management Practice (IMSMP), is the largest MS...

2013-02-22 23:00:30

The MS Center of Atlanta, along with the NMSS (National Multiple Sclerosis Society), are dedicated to remove all barriers to patient care. The Center is proud to team up with GPT (Georgia Partnership of Telehealth) and Dr. Brian Griner to set up the first dedicated telehealth center for MS in Valdosta, Georgia. (PRWEB) February 22, 2013 A significant number of patients in Georgia lack access to physicians knowledgeable about their disease or illness. This is true not only in rural areas,...

2013-02-17 23:01:36

Ironclad Integrity Ltd. announces Dr. Gary M. Levin´s natural Multiple Sclerosis treatment as an alternative therapy that delivers effective results. Denver, CO (PRWEB) February 17, 2013 Health experts know very little about the causes of Multiple Sclerosis. Risk factors are still not accurately highlighted and medicine such as antidepressants, interferons, mioxantrone and steroids features side-effects that many MS patients don´t feel are worth in the long run. According to...